Influence of acetylsalicylic acid (Aspirin) on cutaneous microcirculation

Clinical Hemorheology and Microcirculation

Volumn 50, Issue 1-2, 2012, Pages 25-34

  Leithauser B ^a   Mrowietz, C ^b   Park, J W ^a   Jung, F ^b  

^a Asklepios Klinik Harburg   (Germany)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

Aspirin; microcirculation

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; PROSTAGLANDIN SYNTHASE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; BLOOD PRESSURE; CAPILLARY BLOOD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; MICROSCOPY; NAILFOLD CAPILLARY MICROSCOPY; NORMAL HUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SKIN BLOOD FLOW; VASODILATATION;

ASPIRIN; BLOOD FLOW VELOCITY; CELL MOVEMENT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ERYTHROCYTES; HUMANS; MICROCIRCULATION; NAILS;

EID: 84863362185     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2011-1440     Document Type: Article

References (74)

1. G. Addor, A. Delachaux, B. Dischl, D. Hayoz, L. Liaudet, B. Waeber and F. Feihl, A comparative study of reactive hyperemia in human forearm skin and muscle, Physiol Res 57 (2008), 685-692.
2. S. Alkhayal, V. Lehmann and P. Thomas, A simple noninvasive test to detect vascular disease in patients with erectile dysfunction: A novel method, J Sex Med 3 (2006), 331-336.
3. Anonymous, Ethical guidelines for publication in Clinical Hemorheology and Microcirculation, Clin Hemorheol Microcirc 44 (2010), 1-2.
4. E.H. Awtry and J. Loscalzo, Aspirin, Circulation 101 (2000), 1206-1218. (Pubitemid 30146625)
5. S. Beer, F. Feihl, J. Ruiz, I. Juhan-Vague, M.F. Aillaud, S.G.Wetzel, L. Liaudet, R.C. Gaillard and B.Waeber, Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes, Vasc Health Risk Manag 4 (2008), 1449-1458.
6. J.S. Berger, M.J. Krantz, J.M. Kittelson andW.R. Hiatt, Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: A meta-analysis of randomized trials, JAMA 301 (2009), 1909-1919.
7. C. Binggeli, L.E. Spieker, R. Corti, I. Sudano, V. Stojanovic, D. Hayoz, T.F. Luscher and G. Noll, Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: A monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol 42 (2003), 71-77. (Pubitemid 36760763)
8. L. Bjorklund, M.A. Wallander, S. Johansson and E. Lesen, Aspirin in cardiology-benefits and risks, Int J Clin Pract 63 (2009), 468-477.
9. P.O. Bonetti, G.M. Pumper, S.T. Higano, D.R. Holmes, J.T. Kuvin Jr and A. Lerman, Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia, J Am Coll Cardiol 44 (2004), 2137-2141. (Pubitemid 39576032)
10. G.M. Borthwick, A.S. Johnson, M. Partington, J. Burn, R. Wilson and H.M. Arthur, Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism, FASEB J 20 (2006), 2009-2016. (Pubitemid 44953901)
11. H. Bulckaen, G. Prevost, E. Boulanger, G. Robitaille, V. Roquet, C. Gaxatte, G. Garcon, B. Corman, P. Gosset, P. Shirali, C. Creusy and F. Puisieux, Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging, Am J Physiol Heart Circ Physiol 294 (2008), H1562-H1570. (Pubitemid 351490585)
12. I. Carlsson, B. Linde and A.Wennmalm, Arachidonic acid metabolism and regulation of blood flow: Effect of indomethacin on cutaneous and subcutaneous reactive hyperaemia in humans, Clin Physiol 3 (1983), 365-373. (Pubitemid 13014411)
13. I. Carlsson, A. Sollevi and A.Wennmalm, The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia, J Physiol 389 (1987), 147-161. (Pubitemid 17115793)
14. A.T. Chan, J.E. Manson, C.M. Albert, C.U. Chae, K.M. Rexrode, G.C. Curhan, E.B. Rimm, W.C. Willett and C.S. Fuchs, Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events, Circulation 113 (2006), 1578-1587. (Pubitemid 43739417)
15. A.T. Cheung, M.M. Tomic, P.C. Chen, E. Miguelino, C.S. Li and S. Devaraj, Correlation of microvascular abnormalities and endothelial dysfunction in Type-1 Diabetes Mellitus (T1DM): A real-time intravital microscopy study, Clin Hemorheol Microcirc 42 (2009), 285-295.
16. G.C. Curhan, W.C. Willett, B. Rosner and M.J. Stampfer, Frequency of analgesic use and risk of hypertension in younger women, Arch Intern Med 162 (2002), 2204-2208. (Pubitemid 35231589)
17. A. Dalle-Ave, S. Kubli, S. Golay, A. Delachaux, L. Liaudet, B. Waeber and F. Feihl, Acetylcholine-induced vasodilation and reactive hyperemia are not affected by acute cyclo-oxygenase inhibition in human skin, Microcirculation 11 (2004), 327-336. (Pubitemid 39619083)
18. R.T. de Jongh, E.H. Serne, R.G. Ijzerman, G. de Vries and C.D. Stehouwer, Impaired microvascular function in obesity: Implications for obesity-associated microangiopathy, hypertension, and insulin resistance, Circulation 109 (2004), 2529-2535. (Pubitemid 38720552)
19. E. Dragomir, I. Manduteanu, M. Voinea, G. Costache, A. Manea and M. Simionescu, Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells, J Diabetes Complications 18 (2004), 289-299. (Pubitemid 39165436)
20. G. Eisele, E. Schwedhelm, B. Schieffer, D. Tsikas and R.H. Boger, Acetylsalicylic acid inhibits monocyte adhesion to endothelial cells by an antioxidative mechanism, J Cardiovasc Pharmacol 43 (2004), 514-521. (Pubitemid 39090017)
21. R.S. Farivar and P. Brecher, Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts, J Biol Chem 271 (1996), 31585-31592. (Pubitemid 26408619)
22. J.M. Gaziano, Nonnarcotic analgesics and hypertension, Am J Cardiol 97 (2006), 10-16.
23. T. Gori, G. Di Stolfo, S. Sicuro, S. Dragoni, M. Lisi, J.D. Parker and S. Forconi, Correlation analysis between different parameters of conduit artery and microvascular vasodilation, Clin Hemorheol Microcirc 35 (2006), 509-515. (Pubitemid 44812464)
24. N. Grosser and H. Schroder, Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway, Arterioscler Thromb Vasc Biol 23 (2003), 1345-1351. (Pubitemid 36994520)
25. H.M. Hafner, U. Schmid, M. Moehrle, A. Strolin and H. Breuninger, Changes in acral blood flux under local application of ropivacaine and lidocaine with and without an adrenaline additive: A double-blind, randomized, placebo-controlled study, Clin Hemorheol Microcirc 38 (2008), 279-288. (Pubitemid 351521579)
26. N.M. Hamburg, M.J. Keyes, M.G. Larson, R.S. Vasan, R. Schnabel, M.M. Pryde, G.F. Mitchell, J. Sheffy, J.A. Vita and E.J. Benjamin, Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study, Circulation 117 (2008), 2467-2474. (Pubitemid 351670453)
27. N.M. Hamburg, C.J. McMackin, A.L. Huang, S.M. Shenouda, M.E.Widlansky, E. Schulz, N. Gokce, N.B. Ruderman, J.F. Keaney Jr and J.A. Vita, Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers, Arterioscler Thromb Vasc Biol 27 (2007), 2650-2656. (Pubitemid 350158918)
28. R.C. Hermida, D.E. Ayala, C. Calvo and J.E. Lopez, Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients, J Am Coll Cardiol 46 (2005), 975-983. (Pubitemid 41316502)
29. R.C. Hermida, D.E. Ayala, C. Calvo, J.E. Lopez, A. Mojon, M. Rodriguez and J.R. Fernandez, Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives, Hypertension 46 (2005), 1060-1068.
30. R.H. Hilgers and R.C. Webb, Molecular aspects of arterial smooth muscle contraction: Focus on Rho, Exp Biol Med (Maywood) 230 (2005), 829-835. (Pubitemid 41785882)
31. A.L. Huang, A.E. Silver, E. Shvenke, D.W. Schopfer, E. Jahangir, M.A. Titas, A. Shpilman, J.O. Menzoian, M.T.Watkins, J.D. Raffetto, G. Gibbons, J. Woodson, P.M. Shaw, M. Dhadly, R.T. Eberhardt, J.F. Keaney Jr, N. Gokce and J.A. Vita, Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery, Arterioscler Thromb Vasc Biol 27 (2007), 2113-2119. (Pubitemid 350287238)
32. S. Husain, N.P. Andrews, D. Mulcahy, J.A. Panza and A.A. Quyyumi, Aspirin improves endothelial dysfunction in atherosclerosis, Circulation 97 (1998), 716-720. (Pubitemid 28135332)
33. Y. Ishibashi, N. Takahashi, T. Shimada, T. Sugamori, T. Sakane, T. Umeno, Y. Hirano, N. Oyake and Y. Murakami, Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors, Circ J 70 (2006), 115-123. (Pubitemid 43021244)
34. A.G. Johnson, T.V. Nguyen and R.O. Day,Do nonsteroidal anti-inflammatory drugs affect blood pressure?Ameta-analysis, Ann Intern Med 121 (1994), 289-300.
35. F. Jung, From hemorheology to microcirculation and regenerative medicine: Fa°hraeus Lecture 2009, Clin Hemorheol Microcirc 45 (2010), 79-99.
36. F. Jung,W.Kolepke, S. Spitzer,H. Kiesewetter,K.W. Ruprecht, R. Bach, H. Schieffer and E.Wenzel, Primary and secondary microcirculatory disorders in essential hypertension, Clin Investig 71 (1993), 132-138. (Pubitemid 23051323)
37. F. Jung, C. Mrowietz, C. Labarrere, S. Schüler and J.W. Park, Primary cutaneous microangiopathy in heart recipients, Microvasc Res 62 (2001), 154-163. (Pubitemid 32885702)
38. F. Jung, H. Toonen, C. Mrowietz, S. Wolf, H. Kiesewetter, E. Wenzel and K. Gersonde, and G. Muller. [Error analysis, biological modification factors and variance of peri-ungual video-capillary microscopy], Biomed Tech (Berl) 35 (1990), 195-204.
39. F. Jung, M. Wappler, H.P. Nuttgens, H. Kiesewetter, S. Wolf and G. Muller, [Method of video capillary microscopy: Determination of geometric and dynamic measuring parameters], Biomed Tech (Berl) 32 (1987), 204-213.
40. K.J. Jung, J.Y. Kim, Y. Zou, Y.J. Kim, B.P. Yu and H.Y. Chung, Effect of short-term, low dose aspirin supplementation on the activation of pro-inflammatory NF-kappaB in aged rats, Mech Ageing Dev 127 (2006), 223-230. (Pubitemid 43214494)
41. M. Kato, P. Roberts-Thomson, B.G. Phillips, W.G. Haynes, M. Winnicki, V. Accurso and V.K. Somers, Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea, Circulation 102 (2000), 2607-2610.
42. A. Kimura, J. Roseto, K.Y. Suh, A.M. Cohen and R.J. Bing, Effect of acetylsalicylic acid on nitric oxide production in infarcted heart in situ, Biochem Biophys Res Commun 251 (1998), 874-878. (Pubitemid 28512803)
43. Klinische Arzneimittelprüfung in der EG: Grundsätze für Standards für Good Clinical Practice (GCP) bei der Durchführung von Studien mit Arzneimitteln am Menschen in der EG: EG - GCP - Note for Guidance. Aulendorf: Editio Cantor, 1991
44. T. Klyscz, M. Jünger, F. Jung and H. Zeintl, [Cap image-a new kind of computer-assisted video image analysis system for dynamic capillary microscopy], Biomed Technik 42 (1997), 168-175.
45. J. Koscielny, R. Latza, S. Mörsdorf, C. Mrowietz, H. Kiesewetter, E. Wenzel and F. Jung, Capillary microscopic and rheological dimensions for the diagnosis of vonWillebrand disease in comparison to other haemorrhagic diatheses, Thromb Haemost 84 (2000), 981-988. (Pubitemid 32014033)
46. J. Koscielny, R. Latza, S. Wolf, H. Kiesewetter and F. Jung, Early rheological and microcirculatory changes in children with type I diabetes mellitus, Clin Hemorheol Microcirc 19 (1998), 134-139.
47. I.J.Kullo, A.R. Malik, S. Santos, J.E. Ehrsam and S.T. Turner, Association of cardiovascular risk factors with microvascular and conduit artery function in hypertensive subjects, Am J Hypertens 20 (2007), 735-742. (Pubitemid 46936166)
48. B. Leithäuser, U. Gerk, C. Mrowietz, F. Jung and J.W. Park, Influence of xantinole nicotinic acid on cutaneous microcirculation in patients with coronary artery disease and hyperlipoproteinemia, Clin Hemorheol Microcirc 39 (2008), 287-292. (Pubitemid 352040006)
49. H. Lenasi and M. Strucl, Regular physical activity alters the postocclusive reactive hyperemia of the cutaneous microcirculation, Clin Hemorheol Microcirc 45 (2010), 365-374.
50. G. Loirand, P. Guerin and P. Pacaud, Rho kinases in cardiovascular physiology and pathophysiology, Circ Res 98 (2006), 322-334.
51. M.F. Meyer, D. Lieps, H. Schatz and M. Pfohl, Impaired flow-mediated vasodilation in type 2 diabetes: Lack of relation to microvascular dysfunction, Microvasc Res 76 (2008), 61-65.
52. I.K. Moppett, J.A. Davies and R.P. Mahajan, Non-selective and cyclo-oxygenase-2-specific non-steroidal anti-inflammatory drugs impair the hyperaemic response of skin to brief axillary artery occlusion, Br J Anaesth 91 (2003), 353-356. (Pubitemid 37063350)
53. S. Muxel, F. Fasola, M.C. Radmacher, A. Jabs, T. Münzel and T. Gori, Endothelial functions: Translating theory into clinical application, Clin Hemorheol Microcirc 45 (2010), 109-115.
54. J. Ostergren and B. Fagrell, Skin capillary blood cell velocity in patients with arterial obliterative disease and polycythaemia: A disturbed reactive hyperaemia response, Clin Physiol 5 (1985), 35-43. (Pubitemid 15127753)
55. K. Pahkala, O.J. Heinonen, H. Lagstrom, P. Hakala, O. Simell, J.S. Viikari, T. Ronnemaa, M. Hernelahti, L. Sillanmaki and O.T. Raitakari, Vascular endothelial function and leisure-time physical activity in adolescents, Circulation 118 (2008), 2353-2359.
56. J.W. Park, C. Mrowietz, N. Chung and F. Jung, Sildenafil improves cutaneous microcirculation in patients with coronary artery disease: Amonocentric, prospective, double-blind, placebo-controlled, randomized cross-over study, Clin Hemorheol Microcirc 31 (2004), 173-183. (Pubitemid 39362718)
57. C. Patrono and B. Rocca, Aspirin: Promise and resistance in the new millennium, Arterioscler Thromb Vasc Biol 28 (2008), s25-s32.
58. G.L. Pierce, L.A. Lesniewski, B.R. Lawson, S.D. Beske and D.R. Seals, Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans, Circulation 119 (2009), 1284-1292.
59. J.E. Pope, J.J. Anderson and D.T. Felson, A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure, Arch Intern Med 153 (1993), 477-484. (Pubitemid 23064991)
60. E.G. Salerud, T. Tenland, G.E. Nilsson and P.A. Oberg, Rhythmical variations in human skin blood flow, Int J Microcirc Clin Exp 2 (1983), 91-102.
61. Q.A. Shamim-Uzzaman, D. Pfenninger,C.Kehrer,A. Chakrabarti, N. Kacirotti, M. Rubenfire, R. Brook and S. Rajagopalan, Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: A comparative study with conduit vessel responses, Clin Sci (Lond) 103 (2002), 267-273. (Pubitemid 35007218)
62. K.A. Steer, T.M.Wallace, C.H. Bolton and M. Hartog, Aspirin protects lowdensity lipoprotein from oxidative modification, Heart 77 (1997), 333-337. (Pubitemid 27208173)
63. D. Taubert, R. Berkels, N. Grosser, H. Schroder, D. Grundemann and E. Schomig, Aspirin induces nitric oxide release from vascular endothelium: A novel mechanism of action, Br J Pharmacol 143 (2004), 159-165. (Pubitemid 39280035)
64. The World Medical Association: Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly Helsinki, Finland 1964, 41st World Medical Assembly Hong Kong, September 1989, last amendment 48th General Assembly Somerset West, South Africa, October 1996, Edinburgh 2000.
65. S. Verma, S.R. Raj, L. Shewchuk, K.J. Mather and T.J. Anderson, Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: Randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatation, Circulation 104 (2001), 2879-2882. (Pubitemid 33139096)
66. P. Vuilleumier, D. Decosterd, M. Maillard, M. Burnier and D. Hayoz, Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population, J Hypertens 20 (2002), 1753-1757.
67. J.S.Wasik, R.W. Simon, T. Meier, B. Steinmann and B.R. Amann-Vesti, Nailfold capillaroscopy: Specific features in Fabry disease, Clin Hemorheol Microcirc 42 (2009), 99-106.
68. H.J. Weiss and L.M. Aledort, Impaired platelet-connective-tissue reaction in man after aspirin ingestion, Lancet 2 (1967), 495-497.
69. R. Yamamoto-Suganuma and Y. Aso, Relationship between post-occlusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes, Diabet Med 26 (2009), 83-88.
70. J. Yeboah, G.L. Burke, J.R. Crouse and D.M. Herrington, Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: The Cardiovascular Health Study, Atherosclerosis 197 (2008), 840-845. (Pubitemid 351417883)
71. J. Yeboah, J.R. Crouse, F.C. Hsu, G.L. Burke and D.M. Herrington, Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: The Cardiovascular Health Study, Circulation 115 (2007), 2390-2397. (Pubitemid 46717961)
72. J. Yeboah, A.R. Folsom, G.L. Burke, C. Johnson, J.F. Polak, W. Post, J.A. Lima, J.R. Crouse and D.M. Herrington, Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis, Circulation 120 (2009), 502-509.
73. J. Yeboah, K. Sutton-Tyrrell, M.A. Mcburnie, G.L. Burke, D.M. Herrington and J.R. Crouse, Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: The Cardiovascular Health Study, Atherosclerosis 197 (2008), 768-776. (Pubitemid 351417874)
74. Z. Ying, F.R. Giachini, R.C. Tostes and R.C. Webb, Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation, Cardiovasc Res 83 (2009), 155-162.